Alhemo 40 mg/mL (Concizumab INJECTION, SOLUTION) 40 mg/mL

Alhemo 40 mg/mL is a subcutaneous injection solution containing concizumab. It is used for managing bleeding episodes in hemophilia patients. Learn more about concizumab uses and effects.

Strength

40 mg/mL

Pack Size

1 SYRINGE, PLASTIC in 1 CARTON (0169-2084-15) / 1.5 mL in 1 SYRINGE, PLASTIC

Manufacturer / TM Owner

Novo Nordisk

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Alhemo 40 mg/mL is primarily used for the treatment and prevention of bleeding episodes in individuals with hemophilia. Concizumab, the active ingredient, works by helping to control bleeding. This medication is often prescribed to patients who require ongoing management of their condition. What is Alhemo used for? It is designed to provide support in situations where bleeding control is necessary.

Side Effects

Common effects of Alhemo 40 mg/mL may include localized reactions at the injection site, such as redness, swelling, or itching. Some users might experience mild discomfort or bruising. These effects are generally temporary and should subside over time. If you notice any persistent or severe reactions, consult your healthcare provider.

Precautions & Warnings

Alhemo 40 mg/mL should be handled with care. Ensure the solution is clear and free from particles before use. Store the medication as directed, typically in a refrigerator, to maintain its efficacy. Always follow the instructions provided by your healthcare professional for proper administration and storage.

Avoid Interactions

Alhemo 40 mg/mL may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Avoid alcohol while using this medication, as it may increase the risk of side effects.

Frequently Asked Questions

Alhemo 40 mg/mL is used to manage and prevent bleeding episodes in individuals with hemophilia.

Alhemo 40 mg/mL is administered subcutaneously. Follow the instructions provided by your healthcare provider for proper administration.

Common side effects may include localized reactions at the injection site, such as redness, swelling, or itching.

Alhemo 40 mg/mL may interact with other medications. Consult your healthcare provider before combining it with other drugs.

Store Alhemo 40 mg/mL in a refrigerator as directed. Ensure the solution is clear and free from particles before use.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.